{"id":"https://openalex.org/W85537202","doi":null,"title":"In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).","display_name":"In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): reversal with exogenous erythropoietin (EPO).","alternate_titles":[],"publication_year":1990,"publication_date":"1990-02-01","ids":{"openalex":"https://openalex.org/W85537202","mag":"85537202","pmid":"https://pubmed.ncbi.nlm.nih.gov/2303102"},"language":"en","primary_location":{"id":"pmid:2303102","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2303102","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental hematology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W85537202"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081220639","display_name":"Candace S. Johnson","orcid":"https://orcid.org/0000-0002-1211-4692","observed_orcids":["https://orcid.org/0000-0002-1211-4692"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C S Johnson","raw_affiliation_strings":["Laboratory of Experimental Hematology, AMC Cancer Research Center, Denver, CO 80214"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Experimental Hematology, AMC Cancer Research Center, Denver, CO 80214","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027337355","display_name":"C A Cook","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C A Cook","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5035080887","display_name":"Philip Furmanski","orcid":"https://orcid.org/0009-0003-3931-3004","observed_orcids":["https://orcid.org/0009-0003-3931-3004"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Furmanski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.7692,"has_fulltext":false,"cited_by_count":136,"citation_normalized_percentile":{"value":0.93321851,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"18","issue":"2","first_page":"109","last_page":"113"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.996999979019165},{"id":"https://openalex.org/keywords/erythropoiesis-suppression","display_name":"erythropoiesis inhibition","score":0.8479999899864197},{"id":"https://openalex.org/keywords/erythropoietin","display_name":"erythropoietin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.8610000014305115},{"id":"https://openalex.org/keywords/erythroid-colony-forming-cells","display_name":"erythroid colony-forming cells","score":0.7990000247955322},{"id":"https://openalex.org/keywords/cfu-e","display_name":"CFU-E","score":0.8479999899864197},{"id":"https://openalex.org/keywords/hematocrit","display_name":"hematocrit","score":0.8859999775886536},{"id":"https://openalex.org/keywords/hematopoiesis","display_name":"hematopoiesis","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C2779703530","wikidata":"https://www.wikidata.org/wiki/Q837174","display_name":"Erythropoiesis","level":3,"score":0.8528642654418945},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.8482412695884705},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.7479044795036316},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5611758232116699},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.543876051902771},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5365889668464661},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.536171555519104},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5282289981842041},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.481341689825058},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.4451959729194641},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36493074893951416},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26630735397338867},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000740","descriptor_name":"Anemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004920","descriptor_name":"Erythropoiesis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004921","descriptor_name":"Erythropoietin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006400","descriptor_name":"Hematocrit","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006412","descriptor_name":"Hematopoietic Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008815","descriptor_name":"Mice, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015672","descriptor_name":"Erythroid Precursor Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2303102","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2303102","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental hematology","raw_type":"Journal Article"},{"id":"mag:85537202","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2303102","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7875117956","display_name":"MACROPHAGE CONTROL OF NORMAL AND LEUKEMIC ERYTHROPOIESIS","funder_award_id":"R01CA033188","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8614734860","display_name":"MECHANISMS OF THE ANTILEUKEMIC EFFECTS OF TNF","funder_award_id":"R01CA045674","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G886193778","display_name":"CYTOKINE ENHANCEMENT OF CHEMOTHERAPEUTICS EFFICACY","funder_award_id":"R01CA048077","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2422918612","https://openalex.org/W2462605898","https://openalex.org/W1981675406","https://openalex.org/W67028151","https://openalex.org/W7143284758","https://openalex.org/W2079652091","https://openalex.org/W1977852730","https://openalex.org/W2474354841","https://openalex.org/W2365995719"],"abstract_inverted_index":{"Tumor":[0],"necrosis":[1,152],"factor-alpha":[2],"(TNF-alpha)":[3],"selectively":[4],"kills":[5],"tumor":[6],"cells":[7,104],"in":[8,11,34,106,122,132],"vitro":[9],"and":[10,13,79,109,155],"vivo":[12],"is":[14],"being":[15],"tested":[16],"as":[17],"a":[18,68,123],"cancer":[19],"therapeutic":[20],"agent.":[21],"We":[22],"have":[23,50],"shown":[24],"that":[25,135,169],"TNF-alpha":[26,74,121],"significantly":[27],"suppresses":[28],"late-stage":[29,92],"erythropoiesis,":[30],"leading":[31],"to":[32,58],"anemia":[33],"chronically":[35],"treated":[36,66],"mice.":[37],"These":[38,166],"erythropoietic":[39],"effects":[40,90,179],"could":[41,55],"limit":[42],"the":[43,98,107,117,130,176],"clinical":[44],"use":[45],"of":[46,71,83,100,120,148,153,157,172],"TNF-alpha.":[47,149],"Therefore,":[48],"we":[49],"examined":[51],"whether":[52],"erythropoietin":[53],"(EPO)":[54],"be":[56],"used":[57],"prevent":[59],"TNF-alpha-induced":[60,150,177],"erythroid":[61,102],"suppression.":[62],"Normal":[63],"mice":[64],"were":[65,94,161],"with":[67,78,114,138],"single":[69],"dose":[70],"recombinant":[72,84],"murine":[73],"(10(5)":[75],"U/mouse,":[76],"i.p.)":[77],"without":[80],"various":[81],"concentrations":[82],"human":[85],"EPO.":[86],"After":[87],"3":[88],"days,":[89],"on":[91,180],"erythropoiesis":[93],"measured":[95],"by":[96,163],"determining":[97],"number":[99],"mature":[101],"colony-forming":[103],"(CFU-E)":[105],"spleen":[108],"bone":[110],"marrow.":[111],"Simultaneous":[112],"treatment":[113,127],"EPO":[115,126,164,173],"abrogated":[116],"suppressive":[118,178],"effect":[119],"dose-dependent":[124],"manner.":[125],"also":[128],"prevented":[129],"decrease":[131],"peripheral":[133],"blood-hematocrit":[134],"was":[136],"observed":[137],"chronic":[139],"(5":[140],"x":[141],"10(4)":[142],"U/mouse/day":[143],"for":[144],"5":[145],"days)":[146],"administration":[147],"hemorrhagic":[151],"tumors":[154],"stimulation":[156],"macrophage":[158],"(CFU-M)":[159],"progenitors":[160],"unaffected":[162],"treatment.":[165],"results":[167],"demonstrate":[168],"simultaneous":[170],"injection":[171],"can":[174],"abrogate":[175],"erythropoiesis.":[181]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W85537202","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
